Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heptex
- Development stage
- Phase 2
- Lead developer
- Natural Wellness Biotech
- Administration
- Oral
01
Overview
Heptex is an oral proprietary herbal medicinal product containing powdered extracts of **Phyllanthus niruri** aerial parts and **Silybum marianum** fruit. Each capsule contains 200 mg of Dukung Anak and 100 mg of milk thistle. It has been developed by Natural Wellness as a hepatoprotective, antioxidant botanical product for people with apparent risk factors for nonalcoholic steatohepatitis. In a randomized phase II trial, Heptex was well tolerated over 36 weeks, but changes in ALT, AST, fibrosis measures, and liver-fat measures were not significantly different from placebo between treatment groups; its clinical efficacy therefore remains unconfirmed.
- Brand names
- Heptex
- Other names
- Phyllanthus niruri and Silybum marianum combinationDukung Anak and Milk Thistle combination
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on Heptex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heptex.